| abstract |
Compounds of Formula I wherein R.sup.1.n. means a phenyl, cycloalkyl, cycloalkyl or alkyl group wherein the alkyl group may be substituted by hydroxy, phenyl, alkoxycarbonyl, cycloalkyl or cycloalkyl, R 5, R 2 '. means a substituted or unsubstituted phenyl group, wherein the substituents may be 1 or 2 halogens, alkyls, nitro-cyano, trifluoromethyl, trifluoromethoxy, alkylthio or (CH.sub.2.n.sub.4), where R.sup.4.n. is hydroxy, alkoxy, CO.sub.2. or NR.sup.6.R.sup.7, R.sup.3.n. is phenyl optionally substituted with one or two halogen atoms; is hydrogen or C 1-6 alkyl; and R.sup.7.n. independently of one another are hydrogen or C 1-6 alkyl. R.sup.8.n. is hydrogen or halogen, m is 0, 1 or 2, n is 0 or 1, a process for their preparation, and pharmaceutical compositions based thereon that antagonize the function of gastrin and CCK-B receptors.nŕ |